221 related articles for article (PubMed ID: 16737551)
21. Expression and function of the Eph A receptors and their ligands ephrins A in the rat thymus.
Muñoz JJ; Alonso-C LM; Sacedón R; Crompton T; Vicente A; Jiménez E; Varas A; Zapata AG
J Immunol; 2002 Jul; 169(1):177-84. PubMed ID: 12077243
[TBL] [Abstract][Full Text] [Related]
22. Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.
Toma MI; Erdmann K; Diezel M; Meinhardt M; Zastrow S; Fuessel S; Wirth MP; Baretton GB
PLoS One; 2014; 9(7):e102262. PubMed ID: 25025847
[TBL] [Abstract][Full Text] [Related]
23. EphA2 Transmembrane Domain Is Uniquely Required for Keratinocyte Migration by Regulating Ephrin-A1 Levels.
Ventrella R; Kaplan N; Hoover P; Perez White BE; Lavker RM; Getsios S
J Invest Dermatol; 2018 Oct; 138(10):2133-2143. PubMed ID: 29705292
[TBL] [Abstract][Full Text] [Related]
24. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
25. Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4.
Ieguchi K; Omori T; Komatsu A; Tomita T; Deguchi A; Maru Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):623-9. PubMed ID: 24103748
[TBL] [Abstract][Full Text] [Related]
26. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.
Hafner C; Becker B; Landthaler M; Vogt T
Mod Pathol; 2006 Oct; 19(10):1369-77. PubMed ID: 16862074
[TBL] [Abstract][Full Text] [Related]
27. Eph and ephrin expression in normal placental development and preeclampsia.
Goldman-Wohl D; Greenfield C; Haimov-Kochman R; Ariel I; Anteby EY; Hochner-Celnikier D; Farhat M; Yagel S
Placenta; 2004 Aug; 25(7):623-30. PubMed ID: 15193868
[TBL] [Abstract][Full Text] [Related]
28. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
29. ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
Ieguchi K; Tomita T; Omori T; Komatsu A; Deguchi A; Masuda J; Duffy SL; Coulthard MG; Boyd A; Maru Y
Oncogene; 2014 Apr; 33(17):2179-90. PubMed ID: 23686306
[TBL] [Abstract][Full Text] [Related]
30. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
Carter N; Nakamoto T; Hirai H; Hunter T
Nat Cell Biol; 2002 Aug; 4(8):565-73. PubMed ID: 12134157
[TBL] [Abstract][Full Text] [Related]
31. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.
Bhatia S; Hirsch K; Baig NA; Rodriguez O; Timofeeva O; Kavanagh K; Lee YC; Wang XJ; Albanese C; Karam SD
J Hematol Oncol; 2015 Sep; 8():105. PubMed ID: 26345456
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin.
Vihanto MM; Plock J; Erni D; Frey BM; Frey FJ; Huynh-Do U
FASEB J; 2005 Oct; 19(12):1689-91. PubMed ID: 16081502
[TBL] [Abstract][Full Text] [Related]
33. Architecture of Eph receptor clusters.
Himanen JP; Yermekbayeva L; Janes PW; Walker JR; Xu K; Atapattu L; Rajashankar KR; Mensinga A; Lackmann M; Nikolov DB; Dhe-Paganon S
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10860-5. PubMed ID: 20505120
[TBL] [Abstract][Full Text] [Related]
34. Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Jukonen J; Moyano-Galceran L; Höpfner K; Pietilä EA; Lehtinen L; Huhtinen K; Gucciardo E; Hynninen J; Hietanen S; Grénman S; Ojala PM; Carpén O; Lehti K
Sci Rep; 2021 Apr; 11(1):8856. PubMed ID: 33893375
[TBL] [Abstract][Full Text] [Related]
35. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.
Himanen JP; Goldgur Y; Miao H; Myshkin E; Guo H; Buck M; Nguyen M; Rajashankar KR; Wang B; Nikolov DB
EMBO Rep; 2009 Jul; 10(7):722-8. PubMed ID: 19525919
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma.
Giaginis C; Tsourouflis G; Zizi-Serbetzoglou A; Kouraklis G; Chatzopoulou E; Dimakopoulou K; Theocharis SE
Pathol Oncol Res; 2010 Jun; 16(2):267-76. PubMed ID: 19949912
[TBL] [Abstract][Full Text] [Related]
37. Comparative 3'UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines.
Winter J; Roepcke S; Krause S; Müller EC; Otto A; Vingron M; Schweiger S
PLoS One; 2008 Jul; 3(7):e2780. PubMed ID: 18648668
[TBL] [Abstract][Full Text] [Related]
38. Expression of ephrin-A ligands and EphA receptors in the developing mouse tooth and its supporting tissues.
Luukko K; Løes S; Kvinnsland IH; Kettunen P
Cell Tissue Res; 2005 Jan; 319(1):143-52. PubMed ID: 15517401
[TBL] [Abstract][Full Text] [Related]
39. Functional Roles of Eph A-Ephrin A1 System in Endometrial Luminal Epithelial Cells During Early Pregnancy.
Lim W; Bae H; Bazer FW; Song G
J Cell Physiol; 2017 Jun; 232(6):1527-1538. PubMed ID: 27775163
[TBL] [Abstract][Full Text] [Related]
40. Ephs and ephrins in cancer: ephrin-A1 signalling.
Beauchamp A; Debinski W
Semin Cell Dev Biol; 2012 Feb; 23(1):109-15. PubMed ID: 22040911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
